Filing Details
- Accession Number:
- 0001181431-12-006393
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-07 13:21:08
- Reporting Period:
- 2012-02-03
- Filing Date:
- 2012-02-07
- Accepted Time:
- 2012-02-07 13:21:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1519218 | Andrew Okun | 940 Winter Street Waltham MA 02451 | Vp & Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-03 | 3,334 | $12.95 | 14,069 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-03 | 3,334 | $26.41 | 10,735 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2012-02-03 | 3,334 | $0.00 | 3,334 | $12.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-02-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 18 | Indirect | By 401(K) |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on November 8, 2011.
- This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.